Arena Pharmaceuticals ARNA

Annual report 2021
added 12-16-2023

Arena Pharmaceuticals DPO Ratio 2011-2026 | ARNA

Annual DPO Ratio Arena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	142	57.6	134	220	386	106

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
386	57.6	174

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	Akebia Therapeutics AKBA	168	$ 1.4	-0.71 %	$ 360 M	USA
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Aytu BioScience AYTU	186	$ 2.55	-0.78 %	$ 16 M	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	Amphastar Pharmaceuticals AMPH	31.7	$ 20.37	-2.4 %	$ 952 M	USA
	Aquestive Therapeutics AQST	395	$ 4.08	-2.16 %	$ 436 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	Arcutis Biotherapeutics ARQT	133	$ 24.21	-1.47 %	$ 3.08 B	USA
	BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Celldex Therapeutics CLDX	4.06 K	$ 32.24	-4.1 %	$ 2.14 B	USA
	AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
	Avid Bioservices CDMO	62.3	-	-	$ 789 M	USA